Skip to Content

TAK ALG-12.5 (Alogliptin Benzoate 12.5 mg)

Pill with imprint TAK ALG-12.5 is Yellow, Elliptical / Oval and has been identified as Alogliptin benzoate 12.5 mg. It is supplied by Perrigo New York Inc..

Alogliptin is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Alogliptin 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TAK ALG-12.5

Alogliptin benzoate

TAK ALG-12.5
12.5 mg
Elliptical / Oval
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Perrigo New York Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.